Paul Fleming

3.0k total citations
25 papers, 434 citations indexed

About

Paul Fleming is a scholar working on Nutrition and Dietetics, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Fleming has authored 25 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nutrition and Dietetics, 10 papers in Pediatrics, Perinatology and Child Health and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Fleming's work include Infant Nutrition and Health (13 papers), Neonatal Respiratory Health Research (9 papers) and Infant Development and Preterm Care (7 papers). Paul Fleming is often cited by papers focused on Infant Nutrition and Health (13 papers), Neonatal Respiratory Health Research (9 papers) and Infant Development and Preterm Care (7 papers). Paul Fleming collaborates with scholars based in United Kingdom, Australia and Germany. Paul Fleming's co-authors include Kate Costeloe, Kathryn E. Lancaster, Rose Zulliger, Deena L. Gibbons, Alex Virasami, Marie‐Laure Michel, Neil J. Sebire, Robert Carr, Nigel Klein and Adrian Hayday and has published in prestigious journals such as Nature Medicine, Nature Communications and PEDIATRICS.

In The Last Decade

Paul Fleming

23 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Fleming United Kingdom 10 155 123 114 108 104 25 434
Münevver Türkmen Türkiye 10 122 0.8× 26 0.2× 76 0.7× 29 0.3× 62 0.6× 48 552
Gregory C. Valentine United States 11 105 0.7× 80 0.7× 74 0.6× 26 0.2× 63 0.6× 46 351
Ida Laake Norway 15 313 2.0× 104 0.8× 42 0.4× 52 0.5× 32 0.3× 43 616
Sunita Sharma United States 10 141 0.9× 324 2.6× 10 0.1× 76 0.7× 83 0.8× 27 603
Jennifer Evans United Kingdom 11 81 0.5× 119 1.0× 11 0.1× 51 0.5× 197 1.9× 24 515
P Zvandasara Zimbabwe 8 74 0.5× 149 1.2× 168 1.5× 31 0.3× 15 0.1× 12 396
Shepherd Nhamoyebonde South Africa 4 148 1.0× 234 1.9× 56 0.5× 54 0.5× 17 0.2× 5 409
P Verronen Finland 11 149 1.0× 27 0.2× 73 0.6× 50 0.5× 32 0.3× 17 417
Luiz A.M. Fonseca Brazil 12 137 0.9× 41 0.3× 12 0.1× 91 0.8× 47 0.5× 24 420
José Luis Rodríguez Spain 8 92 0.6× 115 0.9× 66 0.6× 17 0.2× 72 0.7× 12 341

Countries citing papers authored by Paul Fleming

Since Specialization
Citations

This map shows the geographic impact of Paul Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Fleming more than expected).

Fields of papers citing papers by Paul Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Fleming. The network helps show where Paul Fleming may publish in the future.

Co-authorship network of co-authors of Paul Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Fleming. A scholar is included among the top collaborators of Paul Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Fleming. Paul Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szatkowski, Lisa, Janet Berrington, Kate Costeloe, et al.. (2025). Description of probiotic use in preterm infants in England and Wales 2016–2022. BMJ Paediatrics Open. 9(1). e003605–e003605. 1 indexed citations
3.
Hutchinson, Richard A., William G. Wade, Michael Millar, et al.. (2024). Changes in the intestinal microbiome of the preterm baby associated with stopping non-invasive pressure support: a prospective cohort study. BMJ Paediatrics Open. 8(1). e002675–e002675. 2 indexed citations
4.
Aladangady, Narendra, Sven Wellmann, Simon Eaton, et al.. (2024). Pancreatic Insufficiency, Digestive Enzyme Supplementation, and Postnatal Growth in Preterm Babies. Neonatology. 121(3). 283–287.
5.
Paranthaman, Karthik, Allegra Wilson, Neville Q. Verlander, et al.. (2023). Trends in coagulase-negative staphylococci (CoNS), England, 2010–2021. Access Microbiology. 5(6). 5 indexed citations
6.
Berrington, Janet, Lisa Szatkowski, Kate Costeloe, et al.. (2023). How frequent is routine use of probiotics in UK neonatal units?. BMJ Paediatrics Open. 7(1). e002012–e002012. 4 indexed citations
7.
Hutchinson, Richard A., Kate Costeloe, William G. Wade, et al.. (2023). Intravenous antibiotics in preterm infants have a negative effect upon microbiome development throughout preterm life. Gut Pathogens. 15(1). 18–18. 7 indexed citations
8.
Aladangady, Narendra, et al.. (2021). Demand for regional level III neonatal services is not reduced during national COVID lockdowns. Early Human Development. 163. 105491–105491. 2 indexed citations
9.
Fleming, Paul, Chris Gale, Eleanor J. Molloy, et al.. (2021). Paediatric research in the times of COVID-19. Pediatric Research. 90(2). 267–271. 6 indexed citations
10.
Hutchinson, Richard A., Adam Laing, Fiona Stacey, et al.. (2020). Perinatal inflammation influences but does not arrest rapid immune development in preterm babies. Nature Communications. 11(1). 1284–1284. 32 indexed citations
11.
Fleming, Paul, Mark Wilks, Simon Eaton, et al.. (2020). Bifidobacterium breve BBG-001 and intestinal barrier function in preterm babies: Exploratory Studies from the PiPS Trial. Pediatric Research. 89(7). 1818–1824. 9 indexed citations
12.
Fleming, Paul, Janet Berrington, & Susan E Jacobs. (2019). Addressing safety concerns of probiotic use in preterm babies. Early Human Development. 135. 72–74. 19 indexed citations
13.
Costeloe, Kate, et al.. (2019). Historical aspects of probiotic use to prevent necrotising enterocolitis in preterm babies. Early Human Development. 135. 51–57. 12 indexed citations
14.
Hutchinson, Richard A., Paul Fleming, Ajay Sinha, et al.. (2018). Does antibiotic choice for the treatment of suspected late-onset sepsis in premature infants determine the risk of developing necrotising enterocolitis? A systematic review. Early Human Development. 123. 6–10. 1 indexed citations
15.
Rees, Clare M., Nigel Hall, Paul Fleming, & Simon Eaton. (2017). Probiotics for the prevention of surgical necrotising enterocolitis: systematic review and meta-analysis. BMJ Paediatrics Open. 1(1). e000066–e000066. 14 indexed citations
16.
Fleming, Paul, Nigel Hall, & Simon Eaton. (2015). Probiotics and necrotizing enterocolitis. Pediatric Surgery International. 31(12). 1111–1118. 12 indexed citations
17.
Fleming, Paul, et al.. (2014). A national survey of admission practices for late preterm infants in England. BMC Pediatrics. 14(1). 150–150. 26 indexed citations
18.
Gibbons, Deena L., Paul Fleming, Alex Virasami, et al.. (2014). Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nature Medicine. 20(10). 1206–1210. 134 indexed citations
19.
Fleming, Paul, et al.. (2012). Use of continuous positive airway pressure during stabilisation and retrieval of infants with suspected bronchiolitis. Journal of Paediatrics and Child Health. 48(12). 1071–1075. 17 indexed citations
20.
Fleming, Paul, et al.. (2012). Medical retrieval and needs of infants with bronchiolitis: An analysis by gestational age. Journal of Paediatrics and Child Health. 49(3). E227–31. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026